350 related articles for article (PubMed ID: 18008005)
1. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
[TBL] [Abstract][Full Text] [Related]
2. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.
Zuo T; Wang L; Morrison C; Chang X; Zhang H; Li W; Liu Y; Wang Y; Liu X; Chan MW; Liu JQ; Love R; Liu CG; Godfrey V; Shen R; Huang TH; Yang T; Park BK; Wang CY; Zheng P; Liu Y
Cell; 2007 Jun; 129(7):1275-86. PubMed ID: 17570480
[TBL] [Abstract][Full Text] [Related]
3. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
[TBL] [Abstract][Full Text] [Related]
5. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Actions of SKP2 Involves Deregulation of CDK1 Turnover Mediated by FOXM1.
Krishnan A; K D; Babu P S S; Jagadeeshan S; Prasad M; Nair SA
J Cell Biochem; 2017 Apr; 118(4):797-807. PubMed ID: 27684411
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous genetic variations of FOXP3 in Xp11.23 elevate breast cancer risk in Chinese population via skewed X-chromosome inactivation.
Zheng J; Deng J; Jiang L; Yang L; You Y; Hu M; Li N; Wu H; Li W; Li H; Lu J; Zhou Y
Hum Mutat; 2013 Apr; 34(4):619-28. PubMed ID: 23378296
[TBL] [Abstract][Full Text] [Related]
8. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
9. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
10. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
[TBL] [Abstract][Full Text] [Related]
11. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
Appleman LJ; Chernova I; Li L; Boussiotis VA
Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
[TBL] [Abstract][Full Text] [Related]
12. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.
Li W; Wang L; Katoh H; Liu R; Zheng P; Liu Y
Cancer Res; 2011 Mar; 71(6):2162-71. PubMed ID: 21278236
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
15. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
Wang G; Wang J; Chang A; Cheng D; Huang S; Wu D; Sirkisoon S; Yang S; Lin HK; Lo HW; Xiang R; Sun P
Oncogene; 2020 Nov; 39(47):7034-7050. PubMed ID: 32989258
[TBL] [Abstract][Full Text] [Related]
16. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
[TBL] [Abstract][Full Text] [Related]
18. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.
Rosner M; Hengstschläger M
J Biol Chem; 2004 Nov; 279(47):48707-15. PubMed ID: 15355997
[TBL] [Abstract][Full Text] [Related]
19. The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
Hume S; Grou CP; Lascaux P; D'Angiolella V; Legrand AJ; Ramadan K; Dianov GL
Nat Commun; 2021 Nov; 12(1):6959. PubMed ID: 34845229
[TBL] [Abstract][Full Text] [Related]
20. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
